Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The investigators hypothesized that the use of biomarkers of invasive fungal infections would increase the percentage of early discontinuation of empirical antifungal therapy and thus reduce the duration of treatment in ICU patients.
Epistemonikos ID: a1e2e1ac193875d38b185c637bb7206b7e58db43
First added on: May 11, 2024